{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:42:55Z","timestamp":1790872975243,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jbspin.2006.01.022","type":"journal-article","created":{"date-parts":[[2006,6,3]],"date-time":"2006-06-03T11:18:41Z","timestamp":1149333521000},"page":"490-494","source":"Crossref","is-referenced-by-count":43,"title":["Prognostic markers for\u00a0systemic sclerosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Olivier","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2006.01.022_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic cohort","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib2","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib4","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2006.01.022_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis. Demographic, clinical and serologic features and survival in 1012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2006.01.022_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","article-title":"Predictors of survival in systemic sclerosis (scleroderma)","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/rheumatology\/35.11.1122","article-title":"Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population","volume":"35","author":"Bryan","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.revmed.2003.11.012","article-title":"Int\u00e9r\u00eat des anticorps antinucl\u00e9aires pour le diagnostic, la classification et le pronostic de la scl\u00e9rodermie syst\u00e9mique","volume":"25","author":"Hachulla","year":"2004","journal-title":"Rev. Med."},{"key":"10.1016\/j.jbspin.2006.01.022_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM-Scl-75 is the main autoantigen in patients with the polymyosites\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Sem. Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/art.1780370619","article-title":"Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.48.1.73","article-title":"Serological profiles in the connective tissue diseases in Zimbabwean patients","volume":"48","author":"Davis","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2006.01.022_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheum"},{"issue":"Suppl 9","key":"10.1016\/j.jbspin.2006.01.022_bib18","first-page":"S632","article-title":"Antinuclear antibody (ANA) profiles and organ system involvements in 127 French and 247 US adult systemic sclerosis (SSc) patients","volume":"50","author":"Meyer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2006.01.022_bib19","first-page":"795","article-title":"Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis","volume":"31","author":"Vesely","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib20","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib21","first-page":"165","article-title":"Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis","volume":"23","author":"Nagy","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib22","first-page":"298","article-title":"Homocysteine plasma concentration is related to severity of lung impairment in scleroderma","volume":"30","author":"Caramaschi","year":"2003","journal-title":"J. Rheumatol."},{"issue":"Suppl. 2","key":"10.1016\/j.jbspin.2006.01.022_bib23","first-page":"S32","article-title":"Non organ based laboratory markers in systemic sclerosis","volume":"21","author":"McHugh","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib24","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis. A sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.2003.020040","article-title":"Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers","volume":"64","author":"Allanore","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2006.01.022_bib26","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1002\/art.11345","article-title":"N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers","volume":"48","author":"Allanore","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/art.20116","article-title":"Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis","volume":"50","author":"Del Papa","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0248-8663(01)00433-7","article-title":"D\u00e9pistage de l\u2019hypertension art\u00e9rielle pulmonaire au cours de la scl\u00e9rodermie syst\u00e9mique: \u00e9tude d\u2019une cohorte de 67 patients","volume":"21","author":"Launay","year":"2001","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jbspin.2006.01.022_bib29","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets. A marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib30","doi-asserted-by":"crossref","first-page":"R309","DOI":"10.1186\/ar1183","article-title":"Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1","volume":"6","author":"Allanore","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jbspin.2006.01.022_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.2004.023382","article-title":"Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement","volume":"64","author":"Del Rosso","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2006.01.022_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10067-002-0684-z","article-title":"Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities","volume":"22","author":"Riccieri","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jbspin.2006.01.022_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.50.5.337-b","article-title":"Raised concentrations of von Willebrand factor antigen in systemic sclerosis","volume":"50","author":"Blann","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2006.01.022_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.1780380206","article-title":"Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity","volume":"38","author":"Gruschwitz","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2006.01.022_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, \u03b2-thromboglobulin and markers of fibrinolysis in primary Raynaud\u2019s phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann. Rheum. Dis."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T05:22:48Z","timestamp":1547616168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X06001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1297319X06001394"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2006.01.022","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}